Autologous Transplantation of P63⁺ Lung Progenitor Cells in Patients with Bronchiectasis: A Randomized, Single-Blind, Controlled Trial

Researchers investigated the safety and efficacy of autologous P63+ progenitor cell transplantation in a randomized, single-blind, controlled, phase I/II trial.